A Randomized Phase II Study of Sequential Eribulin Versus Paclitaxel Followed by FAC/FEC as Neoadjuvant Therapy in Patients with Operable HER2-Negative Breast Cancer

Bora Lim, Juhee Song, Nuhad K. Ibrahim, Kimberly B. Koenig, Mariana Chavez-MacGregor, Joe E. Ensor, Jill Schwartz Gomez, Savitri Krishnamurthy, Abigail S. Caudle, Simona F. Shaitelman, Gary J. Whitman, Vicente Valero

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'A Randomized Phase II Study of Sequential Eribulin Versus Paclitaxel Followed by FAC/FEC as Neoadjuvant Therapy in Patients with Operable HER2-Negative Breast Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences